Golden State Equity Partners’s Hologic HOLX Stock Holding History

Golden State Equity Partners’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-82	Closed	-$6.2K	–	938
2026 Q1	$6.2K	Sell	82 -5,694	-99%	-$428K	﹤0.01%	1421
2025 Q4	$430K	Sell	5,776 -1,145	-17%	-$83.7K	0.07%	312
2025 Q3	$467K	Buy	6,921 +636	+10%	+$42.2K	0.08%	271
2025 Q2	$410K	Buy	+6,285	New	+$377K	0.08%	280
2025 Q1	–	Sell	-2,933	Closed	-$211K	–	452
2024 Q4	$211K	Sell	2,933 -704	-19%	-$55K	0.04%	402
2024 Q3	$296K	Buy	3,637 +228	+7%	+$18.2K	0.16%	140
2024 Q2	$253K	Buy	+3,409	New	+$256K	0.05%	348
2023 Q4	$209K	Buy	+2,931	New	+$204K	0.05%	336
2022 Q1	–	Sell	-3,786	Closed	-$290K	–	205
2021 Q4	$290K	Buy	3,786 +125	+3%	+$9.19K	0.15%	133
2021 Q3	$270K	Buy	+3,661	New	+$275K	0.11%	187

Other funds holding HOLX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Golden State Equity Partners's HOLX Position: Q2 2026 in Review

Golden State Equity Partners sold out of Hologic (HOLX) in Q2 2026, closing a stake of 82 shares — an estimated $6.2K sold.

Golden State Equity Partners first reported a position in HOLX in Q3 2021 and held it in 10 quarters. The position peaked at $467K in Q3 2025. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

Golden State Equity Partners reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
Golden State Equity Partners sold 82 Hologic shares in Q2 2026, an estimated $6.2K.
Golden State Equity Partners first reported a position in Hologic in Q3 2021 and held it in 10 quarters.
Golden State Equity Partners's Hologic position peaked at $467K in Q3 2025.
3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Golden State Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.